Comment on: "SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response" by Verhoeven et al. Joint Bone Spine 2021;88:105258

Joint Bone Spine. 2022 Oct;89(5):105408. doi: 10.1016/j.jbspin.2022.105408. Epub 2022 May 13.
No abstract available

Keywords: B-cell; COVID-19; Rituximab; T-cell; Vaccine.

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Rituximab / therapeutic use
  • Severe Acute Respiratory Syndrome*
  • Vaccination
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines
  • Rituximab